research Early-Onset Effluvium Secondary to COVID-19: Clinical and Histologic Characterization
COVID-19 can cause hair loss starting as early as 18 days after infection.
Search
for
Sort by
Research
150-180 / 1000+ results 
research Characteristics of Telogen Effluvium in COVID-19 in Western Iran (2020)
COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.
research Telogen Effluvium, Beau's Lines, and Acral Peeling Associated with COVID-19 Infection
A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.
research Race, Ethnicity, and Comorbidities Are Critical Factors in the Diagnosis of Telogen Effluvium During the COVID-19 Pandemic
Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.
research Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.
research Alert to US Physicians: DHEA, Widely Used as an OTC Androgen Supplement, May Exacerbate COVID-19
The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.
research Dermatological Manifestations of COVID-19 in Children
COVID-19 can cause skin problems in children.
research New Insights into Alopecia Areata During COVID-19 Pandemic: When Infection or Vaccination Could Play a Role
COVID-19 infection or vaccination may influence the development of alopecia areata, a type of hair loss.
research COVID-19: A Catalyst for Innovative Hybrid Teledermatology Workflows to Increase Access and Improve Patient Care at a Large Group Practice
A new teledermatology system improved access and reduced wait times for skin care.
research Male Balding as a Major Risk Factor for Severe COVID-19: A Possible Role for Targeting Androgens and Transmembrane Protease Serine 2 to Protect Vulnerable Individuals
Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.
research Androgenetic Alopecia in COVID-19: Compared to What?
Hair loss link to severe COVID-19 unclear.
research Association Between Hair Diseases and COVID-19 Pandemic-Related Stress: A Cross-Sectional Study Analysis
The study suggests pandemic stress might worsen or trigger hair loss problems.
research COVID-19 Lockdown And Beyond: Home Practice Solutions For Developing Microsurgical Skills
Home practice solutions using simple materials can help maintain microsurgical skills during lockdowns.
research Hair and Nail Manifestations of COVID-19
COVID-19 can cause hair loss and nail changes in some patients.
research The Role of Autologous Micrografts Injection from Scalp Tissue in the Treatment of COVID-19 Associated Telogen Effluvium: Clinical and Trichoscopic Evaluation
Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.
research Evaluation of Patients with Telogen Effluvium During the Pandemic: Are Monocytes Responsible for Post COVID-19 Telogen Effluvium?
Monocytes might be linked to hair loss after COVID-19.
research Alopecia and Severity of COVID-19: A Cross-Sectional Study in Peru
Men with hair loss are more likely to experience moderate to severe COVID-19 symptoms.
research Comment on 'Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19'
Hair loss link to COVID-19 severity likely due to other factors.
research Cepharanthine: A Review of the Antiviral Potential of a Japanese-Approved Alopecia Drug in COVID-19
Cepharanthine could be a strong antiviral against COVID-19.
research Impact of Anti-Androgen Therapies on COVID-19 Susceptibility: A Case-Control Study in Male Population from Two COVID-19 Regional Centers of Lombardy, Italy
Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.
research Telogen Effluvium After COVID-19 Vaccination Among Public in Saudi Arabia
Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.
research Rare and Common Manifestations of COVID-19 in Children
COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.
research Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies
COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.
research Diagnosis of Stress-Associated Dermatologic Conditions in New York City Safety-Net Hospitals During the COVID-19 Pandemic
During the COVID-19 pandemic, more people were diagnosed with stress-related skin conditions like acne and temporary hair loss.
research Androgenetic Alopecia and COVID-19: Is There a Clinical Connection?
Androgenetic alopecia severity does not affect COVID-19 severity.
research Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.
research Indirect Skin Sign of COVID-19 Days: Striae Rubrae
The COVID-19 pandemic led to more young people getting red stretch marks due to lifestyle changes like less activity and quick weight gain.
research Covid-19 Patients at Referral to Hospital During the First Peak of Disease: Common Clinical Findings Including Myalgia and Fatigue
Most hospitalized COVID-19 patients experienced shortness of breath, dry cough, fever, muscle pain, and fatigue.
research Relationship Between Hair Shedding and Systemic Inflammation in COVID-19 Pneumonia
Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.
research Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 Participants
COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.